A biotech company may already have the data it needs to answer an important question. The problem is that the answer may be spread across five different systems.
Consider one batch.
The MES knows what happened during execution. The historian captures process conditions. LIMS contains laboratory results. The eQMS holds deviations and investigations. ERP contains material and production information.
The data exists. But bringing it together may still require several people, manual exports and spreadsheets.
This is where life sciences data modernization becomes important.
What Is Data Modernization in Life Sciences?
Data modernization improves how data is collected, connected, structured, governed and used across a life sciences organization. It brings together data from manufacturing, laboratory, quality and enterprise systems to create trusted information for reporting, analytics and AI.
For GxP data, there is another consideration: modernization must preserve the integrity, context and traceability needed for how that data will be used.
Why Is Data Modernization Different in Life Sciences?
Life sciences companies rarely operate from one system.
Data may be spread across:
- Manufacturing Execution Systems (MES)
- Laboratory Information Management Systems (LIMS)
- electronic Quality Management Systems (eQMS)
- Enterprise Resource Planning (ERP)
- SCADA and historians
- laboratory instruments and software
- data warehouses and cloud platforms
- spreadsheets and files
- other enterprise applications
Each system may work well on its own while the data remains difficult to use together.
Imagine a manufacturing team trying to understand why yield declined across several batches.
Process conditions may be in the historian. Batch execution data may be in MES. Test results may be in LIMS. Related deviations may be in the eQMS.
Someone still has to connect the dots.
Data modernization is about making the right data work together.
What Does a Modern Life Sciences Data Environment Look Like?
A modern data environment connects information from different systems and gives it enough structure, context and governance to be used with confidence.
This does not mean every company needs the same architecture. A growing biotech preparing for commercialization should not automatically build the same data environment as a global pharmaceutical company with dozens of manufacturing sites.
The graphic below shows the basic data flow from the source systems to reporting dashboards.
The technology behind each layer can vary. Platforms such as Microsoft Azure, AWS, Snowflake, Databricks or Microsoft Fabric may support parts of the environment.
The important question is not which platform is most popular.
It is: What does your organization need its data to do?
Start With the Question, Not the Technology
It is tempting to start a modernization program by asking:
Should we use a data warehouse or lakehouse?
Should we implement Snowflake or Databricks?
Those questions matter eventually. They are rarely the best place to start.
Start with questions such as:
- Why are certain batches experiencing lower yield?
- Can laboratory and manufacturing results be viewed together?
- Are certain types of deviations increasing?
- Can we compare manufacturing performance across sites?
- How much manual work is required to prepare a product quality review?
- What data would be required for a planned analytics or AI use case?
Once the question is clear, the organization can determine which data is needed, where it lives and what needs to change.
A Practical Life Sciences Data Modernization Roadmap
Data modernization does not have to mean replacing every system or integrating everything at once.
A practical approach can follow six steps.
1. Assess: Understand What You Have
Start by mapping the current environment.
Identify the systems, data sources, owners, interfaces and dependencies involved.
For example, saying “LIMS contains our laboratory data” is not enough.
Which data? Where did it originate? How is the batch identified? Does the same identifier appear in MES? Where does the information go next? Which decisions depend on it?
A useful current-state assessment shows how data actually moves through the organization, including the manual steps between systems.
2. Prioritize: Decide What You Need the Data to Do
Not every data source needs to be modernized at once.
Start with valuable use cases.
A company may want to improve manufacturing reporting, combine process and laboratory data, identify quality trends, compare performance across sites, reduce manual data preparation or prepare trusted data for analytics and AI.
This keeps modernization focused on a business outcome instead of simply moving more data.
3. Architect: Design Around the Use Case
Once the use case and required data are understood, the target architecture can be designed.
That might include a data warehouse, data lake, lakehouse or a combination.
- A data warehouse typically contains organized data prepared for defined reporting and analytics.
- A data lake can hold large amounts of structured and unstructured data, often closer to its original form.
- A lakehouse combines characteristics of both approaches.
There is no single correct choice for every life sciences organization. The right architecture depends on the data, scale, use cases, existing technology, security needs, regulatory context and future plans.
4. Connect and Harmonize: Make the Data Work Together
This is where data engineering becomes visible.
APIs and data pipelines can connect systems and move information into the target data environment. ETL or ELT processes can extract, transform and load data automatically.
But moving data is only part of the problem.
Imagine three systems:
MES: Batch_ID
LIMS: Lot_Number
ERP: Production_ID
Before analyzing the information together, the organization needs to determine whether those fields represent the same thing and establish how they relate.
The same issue can occur with product names, equipment identifiers, units, timestamps and site terminology. That may require common identifiers, standardized terminology, master and reference data, consistent units and reusable data models.
5. Govern and Verify: Make the Data Trustworthy
Making data available is not the same as making it trustworthy.
Suppose a manufacturing dashboard reports:
- Batch Yield: 87.4%
A user should be able to understand what sits behind that number.
Where did the source data come from? Which batch does it represent? Was the data transformed? Which calculation was applied? Was all expected data received? Can the result be traced back to its source?
This is where data quality, metadata, reconciliation, lineage, ownership and access controls matter.
Governance also answers practical questions:
- Who owns this data?
- What does it mean?
- Who can access it?
- How important is it?
- How do we know it is reliable?
For example, Manufacturing, Quality and Operations may each calculate “batch cycle time” differently. Putting all three calculations into a cloud platform does not resolve the difference.
The organization first needs to agree on what the metric means. That is governance.
6. Use and Scale: Put the Data to Work
Once trusted data is available, it can support:
- reporting and dashboards
- cross-system analytics
- manufacturing intelligence
- quality insights
- process improvement
- AI and machine learning
The organization can then expand the same foundation to additional systems, sites and use cases.
This is usually more practical than trying to connect everything at once.
What Changes When the Data Is GxP?
This is an important distinction in life sciences.
The question is not simply whether a company is operating in a regulated industry.
Ask:
How will the data be used?
What decisions depend on it?
What is the risk if it is incomplete, incorrect or changed?
The answers can affect how the data and the technology supporting it should be controlled.
| General Data Modernization | GxP-Aware Data Modernization |
| Move data | Preserve integrity and context |
| Transform data | Understand and control critical transformations |
| Build pipelines | Maintain appropriate traceability |
| Migrate records | Map, reconcile and verify data |
| Manage access | Apply appropriate access controls |
| Monitor quality | Define controls based on intended use and criticality |
| Change a pipeline | Assess the impact on regulated use |
| Prepare AI datasets | Maintain appropriate provenance and traceability |
This does not mean every pipeline, dataset or analytics environment requires the same level of control.
A dataset used for exploratory business analytics may have a very different risk profile from information used to support a GMP quality decision.
The approach should reflect intended use, data criticality and risk.
FDA’s drug CGMP data-integrity guidance similarly emphasizes reliable and accurate data while allowing flexible, risk-based strategies for managing data-integrity risks.
When Is Life Sciences Data Ready for Analytics and AI?
Having a large amount of data does not make an organization AI-ready.
Consider an AI application intended to identify relationships between manufacturing conditions and quality events.
It may need:
Historian data + MES data + LIMS results + eQMS events
If those systems cannot reliably identify the same batch, the AI has a problem before a model is even built.
Data intended for analytics or AI should be relevant to the use case, accessible, sufficiently complete, consistently understood and appropriately traceable.
AI readiness often starts as a data engineering problem. Before asking what AI can learn from the data, make sure the data can be reliably connected and understood.
One Batch, Five Systems: A Simple Example
Consider one manufactured batch.
ERP contains the material and production information.
MES contains the manufacturing execution record.
The historian contains process parameters and conditions.
LIMS contains laboratory testing and results.
The eQMS contains related deviations, investigations or CAPAs.
Before modernization
A process engineer investigating an issue may need to search several systems, export files, reconcile identifiers and manually combine the information.
A significant amount of time is spent preparing the data before anyone can analyze it.
After modernization
Data pipelines can bring the required information together.
Common identifiers connect related records. Harmonization gives the data consistent meaning. Quality checks identify missing or unexpected information. Lineage shows where the data originated and how it was transformed.
The engineer can spend more time answering the question and less time assembling the information needed to investigate it.
Where Should a Biotech or Pharma Company Start?
You do not need to connect 25 systems to begin modernizing your data.
Start with one valuable problem.
For example, a biotech may want better visibility into manufacturing performance.
The first phase might connect MES, LIMS and historian data around a defined set of manufacturing questions.
That creates an opportunity to establish the architecture, pipelines, common identifiers, quality rules and governance approach on a manageable scale.
Then expand.
A practical sequence is:
- Pick a problem
- Find the data
- Understand the gaps
- Build the smallest useful foundation
- Prove value
- Scale
Data modernization should be a roadmap, not a big-bang technology project.
Frequently Asked Questions
What is life sciences data modernization?
Life sciences data modernization improves how data is collected, connected, structured, governed and used across systems such as MES, LIMS, eQMS, ERP and laboratory platforms. The goal is to create trusted data that can support operations, reporting, analytics and AI while addressing applicable GxP considerations.
What is the difference between data modernization and data migration?
Data migration focuses primarily on moving data from one location or system to another. Data modernization is broader. It may include migration, but also addresses architecture, integration, data models, quality, governance, lineage and how the data will ultimately be used.
What is life sciences data engineering?
Life sciences data engineering is the work required to collect, move, transform, harmonize and organize data from systems used across pharmaceutical and biotech operations. This can include APIs, ETL/ELT processes, automated pipelines, data models and data quality controls.
How do you modernize GxP data?
Start with the intended use and criticality of the data. Then determine the appropriate controls for integrity, transformation, reconciliation, traceability, access and change. The level of assurance should reflect the risk associated with how the data and resulting information will be used.
What systems are commonly involved in pharma data modernization?
Common sources include MES, LIMS, eQMS, ERP, SCADA, historians, laboratory systems and other manufacturing and enterprise applications. The systems included should be driven by the problem being solved rather than an objective to integrate everything.
What makes life sciences data AI-ready?
AI-ready data is not simply digitized data. It needs to be relevant to the use case, accessible, sufficiently complete, consistently understood and appropriately traceable. For regulated applications, additional controls may be appropriate based on intended use and risk.
Building a Practical Data Foundation
Life sciences companies do not necessarily need more data. They need to make the data they already generate easier to connect, understand and trust.
Assurea helps biotech and pharmaceutical organizations assess their current data environments and build practical modernization roadmaps. Our services span data strategy and architecture, data integration and engineering, cloud data platform modernization, data governance and quality, and analytics and AI-ready data foundations.
What makes this work different in life sciences is the environment around the data. Manufacturing, laboratory and quality information may support regulated processes and decisions. Data engineering and GxP considerations therefore cannot always be treated as separate conversations.
The starting point does not need to be a major transformation.
Start with the problem you are trying to solve. Then determine what your data needs to do differently.